Nscale, vVARDIS, Kry — IPO scrutiny and digital health consolidation — Daily News November 13, 2026
About this episode
The episode compares three paths to scale: Nscale’s amended IPO filing pairs sharp revenue growth with heavy losses; vVARDIS priced its listing below the initial range; and Kry announced the acquisition of Min Doktor, subject to regulatory approval. Markets now demand financial structure, access to capital and real distribution.
Europe's most interesting startup stories. Every week.
No spam. Unsubscribe anytime.
Main news
Startups mentioned
Nscale
AI cloud and data centres with a registered office in London and a campus in Norway. 2026 Series C at a $14.6 billion post-money valuation; IPO only proposed.
vVARDIS
Swiss dental medtech selling dentists Curodont, a peptide-based treatment for early carious lesions.
Kry
Swedish digital health platform with physical clinics, headquartered in Stockholm. Valued at $2B in the 2021 Series D; the current value is not verified.
Min Doktor
Swedish healthcare provider combining digital consultations, clinics next to pharmacies and supermarkets, and vaccinations.